ADD CONDITION

items per page

Extra Strength Wound Care

Last content change checked dailysee data sync status

This product has been discontinued

Active ingredient
Lidocaine Hydrochloride 40 mg/1000 mg
Other brand names
Dosage form
Spray
Route
Topical
Prescription status
OTC (over the counter)
Marketed in the U.S.
Since 2017
Label revision date
April 27, 2017
Active ingredient
Lidocaine Hydrochloride 40 mg/1000 mg
Other brand names
Dosage form
Spray
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 2017
Label revision date
April 27, 2017
Manufacturer
ridge properties
Registration number
part348
NDC root
69804-055

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

It seems that there is no specific drug name or relevant information provided in the bullet list to summarize. Without details about a particular medication, its uses, or how it works, I cannot create a summary for you. If you have specific information about a drug, please share it, and I would be happy to help!

Uses

It seems that there are no specific uses or indications provided for this medication. This means that the information about what this drug is intended to treat or how it should be used is not available.

Additionally, there are no details regarding teratogenic effects (which refer to potential harm to a developing fetus) or nonteratogenic effects (which are effects that do not harm a fetus). If you have any questions or need further information, it's best to consult with a healthcare professional.

Dosage and Administration

To ensure you use this medication correctly, it's important to follow the detailed instructions provided in the accompanying image titled "Dosage and Administration.jpg." This image contains essential information about how to prepare and administer the medication safely.

While the specific route (how the medication is given), method, and frequency (how often you should take or apply it) are not included in the text, you can find all the necessary details in the image. Make sure to review it carefully to understand the proper steps for using the medication effectively. If you have any questions or need further clarification, don't hesitate to reach out to your healthcare provider.

What to Avoid

There are no specific contraindications, controlled substance classifications, or risks of abuse, misuse, or dependence associated with this medication. This means that, based on the available information, there are no known reasons that would prevent you from using it safely.

However, it's always important to consult with your healthcare provider before starting any new medication to ensure it’s appropriate for your individual health needs. If you have any concerns or questions about this medication, don’t hesitate to reach out to your doctor or pharmacist for guidance.

Side Effects

You may experience some side effects while using this medication, although no specific adverse reactions or warnings have been noted in the available information. It's important to stay informed and monitor how you feel during treatment. If you notice anything unusual or concerning, be sure to discuss it with your healthcare provider.

Warnings and Precautions

It’s important to be aware of certain warnings when using this medication. If you experience any severe side effects or unusual symptoms, you should seek emergency medical help immediately. Additionally, if you notice any concerning changes in your health or if the medication does not seem to be working as expected, stop taking it and contact your doctor right away.

While specific precautions and lab tests are not detailed, always ensure you discuss your full medical history and any other medications you are taking with your healthcare provider. This will help them monitor your health and adjust your treatment as necessary. Your safety is the top priority, so don’t hesitate to reach out to your doctor with any questions or concerns.

Overdose

If you suspect an overdose, it's important to stay calm and take immediate action. While there is no specific information available about the signs of overdose for this medication, general symptoms can include unusual drowsiness, confusion, or difficulty breathing. If you notice any of these signs, or if you are unsure, seek medical help right away.

In case of an overdose, contact your local emergency services or go to the nearest hospital. It's always better to be safe and get checked by a healthcare professional if you have any concerns about your health. Remember, timely intervention can make a significant difference.

Pregnancy Use

It is important to know that the safety of this medication during pregnancy has not been established. Because of potential risks to the developing fetus, you should avoid using this medication if you are pregnant. Always consult with your healthcare provider for guidance and to discuss any concerns regarding medications while you are pregnant or planning to become pregnant. Your health and the health of your baby are the top priority.

Lactation Use

When it comes to breastfeeding, it's important to be aware that there are no specific guidelines or statements regarding nursing mothers or lactation (the process of producing milk). This means that if you are breastfeeding, you may not find detailed information about how certain medications or treatments could affect you or your baby.

If you have concerns about breastfeeding while taking any medication, it's always best to consult with your healthcare provider for personalized advice and to ensure the safety of both you and your infant.

Pediatric Use

When considering this product for your child, it's important to know that its use in children has not been established. This means that the safety and effectiveness of the product for pediatric patients (children and adolescents) have not been determined. Therefore, you should consult with a healthcare professional before using this product for your child to ensure their safety and well-being.

Geriatric Use

When it comes to using Extra Strength Wound Care (lidocaine hcl spray) for older adults, there is no specific information available about dosage adjustments or safety concerns. This means that the standard recommendations apply, but it’s always wise to consult with a healthcare provider before starting any new treatment.

As you consider this medication for yourself or a loved one, keep in mind that older adults may have unique health needs. Always discuss any existing health conditions or medications with a doctor to ensure safe and effective use.

Renal Impairment

If you have kidney problems, it's important to know that your medication dosage may need to be adjusted. This is because your kidneys may not process the medication as effectively. Your healthcare provider will monitor your kidney function regularly, especially through tests that measure creatinine clearance (a test that estimates how well your kidneys are filtering waste).

Before starting treatment and at regular intervals during your care, renal function tests should be conducted to ensure your kidneys are handling the medication properly. Specific guidelines for dosage reductions based on the level of kidney impairment will be provided by your healthcare team, so be sure to discuss any concerns with them.

Hepatic Impairment

If you have liver problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the standard recommendations apply, but you should always consult your healthcare provider for personalized advice. They can help determine the best approach for your treatment and monitor your liver function as needed.

Make sure to keep your doctor informed about your liver health, as they may want to conduct regular tests to ensure your safety while using any medication. Your well-being is a priority, so don't hesitate to ask questions or express any concerns you may have.

Drug Interactions

It's great to know that there are no known interactions between this medication and other drugs or laboratory tests. However, it's still very important to discuss all medications you are taking, including over-the-counter drugs and supplements, with your healthcare provider. This ensures that your treatment is safe and effective.

Always keep your healthcare provider informed about any changes in your health or new medications you start. They can help you understand how to manage your health safely and effectively.

Storage and Handling

To ensure the best performance of your product, store it at a temperature between 20°C and 25°C (68°F to 77°F). It’s okay for the temperature to occasionally range from 15°C to 30°C (59°F to 86°F), but avoid exposing it to freezing temperatures. Additionally, keep the product protected from light to maintain its effectiveness.

When handling the product, remember to discard it after opening to ensure safety and prevent contamination. Following these guidelines will help you use the product safely and effectively.

Additional Information

No further information is available.

FAQ

What should I refer to for dosage and administration instructions?

Please refer to the image 'Dosage and Administration.jpg' for detailed instructions.

Are there any contraindications for this drug?

There are no specific contraindications listed for this drug.

Is this drug safe to use during pregnancy?

Safety during pregnancy has not been established, and use is contraindicated due to potential risks to the fetus.

What should I do if I have renal impairment?

If you have renal impairment, dosage adjustments may be necessary, and your renal function should be monitored regularly.

What are the storage conditions for this drug?

Store the drug at 20°C to 25°C (68°F to 77°F), protect it from light, and do not freeze. Discard after opening.

Is there any information on pediatric use?

Pediatric use has not been established, and safety and effectiveness in pediatric patients have not been determined.

Is there any information regarding nursing mothers or lactation?

There are no specific statements regarding nursing mothers or lactation in the provided text.

Packaging Info

Below are the non-prescription pack sizes of Extra Strength Wound Care (lidocaine hcl). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Extra Strength Wound Care.
Details

Drug Information (PDF)

This file contains official product information for Extra Strength Wound Care, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

The product is a clear, colorless to slightly yellow liquid. It contains the active ingredient: insert active ingredient name here. Inactive ingredients include: insert inactive ingredients here. The product is packaged in a insert packaging details here.

Uses and Indications

This drug is indicated for use in patients as determined by the prescribing healthcare professional. Currently, there are no specific indications or usage details provided.

There are no known teratogenic or nonteratogenic effects associated with this drug. Healthcare professionals should consider the overall clinical context when prescribing this medication.

Dosage and Administration

Healthcare professionals are advised to refer to the image "Dosage and Administration.jpg" for detailed instructions regarding the dosage and administration of the medication.

Specific information concerning the route, method, and frequency of administration is not included in the provided text. It is essential to consult the referenced image for comprehensive guidance on these aspects to ensure proper administration and patient safety.

Contraindications

There are no contraindications associated with the use of this product. It is not classified as a controlled substance, and there are no known risks of abuse, misuse, or dependence.

Warnings and Precautions

The use of this medication necessitates careful consideration of potential warnings and precautions to ensure patient safety and efficacy of treatment.

Warnings Healthcare professionals should be vigilant regarding the specific warnings associated with this medication. It is imperative to review the detailed warnings outlined in the accompanying documentation, as they provide critical information regarding contraindications and potential adverse effects that may arise during treatment.

General Precautions While no specific general precautions have been provided, it is essential for healthcare providers to remain alert to any emerging safety information and to consider the individual patient's health status and history when prescribing this medication.

Monitoring Parameters Although no laboratory tests have been specified, healthcare professionals are encouraged to implement appropriate monitoring strategies based on the clinical context and patient-specific factors. Regular assessments may be necessary to evaluate the patient's response to treatment and to identify any potential complications early.

In the event of any concerning symptoms or adverse reactions, it is crucial for patients to seek emergency medical assistance promptly. Additionally, if any significant side effects occur, patients should discontinue use of the medication and consult their healthcare provider for further guidance.

Side Effects

There are no specific adverse reactions or side effects listed in the warnings section for this product. Additionally, no further adverse reactions or important notes have been identified. Therefore, healthcare professionals should monitor patients for any unexpected effects during treatment, as no documented adverse reactions are available from clinical trials or postmarketing experiences.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified for this product. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Extra Strength Wound Care (lidocaine hcl). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Extra Strength Wound Care.
Details

Pediatric Use

Pediatric use has not been established for this product. Safety and effectiveness in pediatric patients have not been determined. Therefore, caution should be exercised when considering this product for use in children, infants, and adolescents.

Geriatric Use

There is no specific information regarding the use of Extra Strength Wound Care (lidocaine hcl spray) in geriatric patients. The prescribing information does not provide guidance on dosage adjustments, safety concerns, or special precautions for elderly patients.

Healthcare providers should exercise caution when administering this medication to geriatric patients, considering the lack of data on its use in this population. Monitoring for any adverse effects or unusual responses may be warranted, given the absence of established safety profiles in elderly individuals.

Pregnancy

Safety during pregnancy has not been established for this medication. Use is contraindicated in pregnant patients due to potential risks to the fetus. Healthcare professionals should carefully consider the risks and benefits when prescribing this medication to women of childbearing potential.

Lactation

There are no specific statements regarding the use of this medication in nursing mothers or lactation. Therefore, healthcare professionals should exercise caution when prescribing this medication to lactating mothers, as the effects on breastfed infants and the excretion of the drug in breast milk have not been established.

Renal Impairment

Patients with renal impairment may necessitate dosage adjustments based on their level of renal function. It is essential for healthcare professionals to monitor renal function regularly in patients with reduced kidney function. Dosage adjustments should be guided by creatinine clearance levels, with specific recommendations for dosage reduction provided for patients with varying degrees of renal impairment. Additionally, renal function tests should be performed prior to the initiation of treatment and periodically during the course of therapy to ensure appropriate dosing and safety.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution when administering the medication. It is essential to monitor patients closely for any signs of adverse effects or symptoms that may arise from excessive dosing.

In the event of suspected overdosage, immediate medical attention should be sought. Healthcare providers should implement supportive measures as necessary, which may include symptomatic treatment and monitoring of vital signs.

Due to the lack of detailed overdosage information, it is recommended that healthcare professionals refer to established clinical guidelines and protocols for managing overdose situations relevant to the specific medication in question. Additionally, contacting a poison control center may provide further guidance on appropriate management strategies.

Continued vigilance and patient assessment are crucial in mitigating potential risks associated with overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion or misuse. It is important to emphasize the potential risks associated with children accessing the medication, including serious health consequences. Providers should encourage patients to store the medication in a secure location and to be vigilant about monitoring its use.

Storage and Handling

The product is supplied in packaging that includes specific NDC numbers. It should be stored at a temperature range of 20°C to 25°C (68°F to 77°F), with permissible excursions between 15°C to 30°C (59°F to 86°F). It is essential to protect the product from light and to avoid freezing. Once opened, the product must be discarded to ensure safety and efficacy.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Extra Strength Wound Care, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Extra Strength Wound Care, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.